Skip Navigation

This Article
Right arrow Full Text (PDF )
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (81)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Nahum, R.
Right arrow Articles by Hillier, S.G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Nahum, R.
Right arrow Articles by Hillier, S.G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 10, No. 1, pp. 75-81, 1995
© 1995 European Society of Human Reproduction and Embryology

Metabolic regulation of androgen production by human thecal cells in vitro

R. Nahum, K.J. Thong and S.G. Hillier1

Reproductive Endocrinology Laboratory, Department of Obstetrics and Gynaecology, University of Edinburgh Centre for Reproductive Biology 37 Chalmers Street, Edinburgh EH3 9EW, UK

Correspondence: 1To whom correspondence should be addressed

The association between hyperinsulinaemia and hyperandrogenism in many women with polycystic ovarian syndrome (PCOS) implies roles for insulin and insulin-like growth factors (IGFs) in the regulation of ovarian androgen production. The aim of the present study was to compare the abilities of insulin, IGF-I and IGF-II to stimulate androgen production by human thecal cells in vitro. Serum-free monolayer cell cultures were established from the ovaries of euandrogenic women undergoing hysterectomy with oophorectomy for non-ovarian indications. Androgen (androstenedione) production was determined after 4 days of culture in the presence of insulin or either of the IGFs (10–100 ng/ml), with and without a maximal stimulatory dose of luteinizing hormone (LH; 10 ng/ml). Interactions with inhibin (30 ng/ml), a putative paracrine regulator of ovarian androgen synthesis, were also tested. The three metabolic hormones exerted similar dose-related effects on androgen production (ED50 ≤10 ng/ml), which were augmented 2- to 3-fold in the presence of LH and further increased several-fold by the additional presence of inhibin. No treatment with insulin or either IGF stimulated thecal cell growth, but all treatments caused striking morphological changes consistent with enhanced steroidogenesis. These results reveal potent regulatory effects of metabolic hormones on human thecal androgen synthesis, which imply (i) ‘progonadotrophic’ roles for insulin and IGF-I in regulating normal ovarian androgen production, (ii) a role for insulin in the aetiology of hyperandrogenism (both with and without hyperinsulinism) in PCOS and (iii) paracrine roles for granulosa-derived IGF-II and inhibin in regulating ovarian androgen production.

Key words: androgen synthesis/human thecal cells/insulin/IGF-I and II

Submitted on June 20, 1994; accepted on September 16, 1994.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
A. Wallin, M. Ghahremani, P. Dahm-Kahler, and M. Brannstrom
Viability and function of the cryopreserved whole ovary: in vitro studies in the sheep
Hum. Reprod., July 1, 2009; 24(7): 1684 - 1694.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. R. Aroda, T. P. Ciaraldi, P. Burke, S. Mudaliar, P. Clopton, S. Phillips, R. J. Chang, and R. R. Henry
Metabolic and Hormonal Changes Induced by Pioglitazone in Polycystic Ovary Syndrome: A Randomized, Placebo-Controlled Clinical Trial
J. Clin. Endocrinol. Metab., February 1, 2009; 94(2): 469 - 476.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. S. Wachs, M. S. Coffler, P. J. Malcom, S. Shimasaki, and R. J. Chang
Increased Androgen Response to Follicle-Stimulating Hormone Administration in Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1827 - 1833.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L.J. Spicer and P.Y. Aad
Insulin-Like Growth Factor (IGF) 2 Stimulates Steroidogenesis and Mitosis of Bovine Granulosa Cells Through the IGF1 Receptor: Role of Follicle-Stimulating Hormone and IGF2 Receptor
Biol Reprod, July 1, 2007; 77(1): 18 - 27.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
N. S. Macklon, R. L. Stouffer, L. C. Giudice, and B. C. J. M. Fauser
The Science behind 25 Years of Ovarian Stimulation for in Vitro Fertilization
Endocr. Rev., April 1, 2006; 27(2): 170 - 207.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
L. J. Spicer
Proteolytic Degradation of Insulin-Like Growth Factor Binding Proteins by Ovarian Follicles: A Control Mechanism for Selection of Dominant Follicles
Biol Reprod, May 1, 2004; 70(5): 1223 - 1230.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
I. Munir, H.-W. Yen, D. H. Geller, D. Torbati, R. M. Bierden, S. R. Weitsman, S. K. Agarwal, and D. A. Magoffin
Insulin Augmentation of 17{alpha}-Hydroxylase Activity Is Mediated by Phosphatidyl Inositol 3-Kinase But Not Extracellular Signal-Regulated Kinase-1/2 in Human Ovarian Theca Cells
Endocrinology, January 1, 2004; 145(1): 175 - 183.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. J. Zeleznik, L. Little-Ihrig, and S. Ramasawamy
Administration of Insulin-Like Growth Factor I to Rhesus Monkeys Does Not Augment Gonadotropin-Stimulated Ovarian Steroidogenesis
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5722 - 5729.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Mendoza, E. Ruiz-Requena, E. Ortega, N. Cremades, F. Martinez, R. Bernabeu, E. Greco, and J. Tesarik
Follicular fluid markers of oocyte developmental potential
Hum. Reprod., April 1, 2002; 17(4): 1017 - 1022.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
A. J. Duleba, T. Pehlivan, R. Carbone, and R. Z. Spaczynski
Activin Stimulates Proliferation of Rat Ovarian Thecal-Interstitial Cells
Biol Reprod, September 1, 2001; 65(3): 704 - 709.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. J. Jakimiuk, S. R. Weitsman, A. Navab, and D. A. Magoffin
Luteinizing Hormone Receptor, Steroidogenesis Acute Regulatory Protein, and Steroidogenic Enzyme Messenger Ribonucleic Acids Are Overexpressed in Thecal and Granulosa Cells from Polycystic Ovaries
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1318 - 1323.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
E. V. Solovyeva, M. Hayashi, K. Margi, C. Barkats, C. Klein, A. Amsterdam, A. J.W. Hsueh, and A. Tsafriri
Growth Differentiation Factor-9 Stimulates Rat Theca-Interstitial Cell Androgen Biosynthesis
Biol Reprod, October 1, 2000; 63(4): 1214 - 1218.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
I.R. Pirwany, R.W.S. Yates, I.T. Cameron, and R. Fleming
Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea
Hum. Reprod., December 1, 1999; 14(12): 2963 - 2968.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
H. J. H. M. T. van Dessel, P. D. K. Lee, G. Faessen, B. C. J. M. Fauser, and L. C. Giudice
Elevated Serum Levels of Free Insulin-Like Growth Factor I in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3030 - 3035.
[Abstract] [Full Text]


Home page
Endocr. Rev.Home page
L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice
The Insulin-Related Ovarian Regulatory System in Health and Disease
Endocr. Rev., August 1, 1999; 20(4): 535 - 582.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A.M. Fulghesu, F. Cucinelli, V. Pavone, F. Murgia, M. Guido, A. Caruso, S. Mancuso, and A. Lanzone
Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome
Hum. Reprod., March 1, 1999; 14(3): 611 - 617.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
C. Mendoza, N. Cremades, E. Ruiz-Requena, F. Martinez, E. Ortega, S. Bernabeu, and J. Tesarik
Relationship between fertilization results after intracytoplasmic sperm injection, and intrafollicular steroid, pituitary hormone and cytokine concentrations
Hum. Reprod., March 1, 1999; 14(3): 628 - 635.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. E. Nestler, D. J. Jakubowicz, W. S. Evans, and R. Pasquali
Effects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary Syndrome
N. Engl. J. Med., June 25, 1998; 338(26): 1876 - 1880.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. E. Nestler, D. J. Jakubowicz, A. Falcon de Vargas, C. Brik, N. Quintero, and F. Medina
Insulin Stimulates Testosterone Biosynthesis by Human Thecal Cells from Women with Polycystic Ovary Syndrome by Activating Its Own Receptor and Using Inositolglycan Mediators as the Signal Transduction System
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2001 - 2005.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
D. S. Willis, H. D. Mason, H. Watson, and S. Franks
Developmentally Regulated Responses of Human Granulosa Cells to Insulin-Like Growth Factors (IGFs):IGF-I and IGF-II Action Mediated Via the Type-I IGF Receptor
J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1256 - 1259.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
J. E. Nestler and D. J. Jakubowicz
Lean Women with Polycystic Ovary Syndrome Respond to Insulin Reduction with Decreases in Ovarian P450c17{alpha} Activity and Serum Androgens
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4075 - 4079.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Nader, M. G. Riad-Gabriel, and M. F. Saad
The Effect of a Desogestrel-Containing Oral Contraceptive on Glucose Tolerance and Leptin Concentrations in Hyperandrogenic Women
J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 3074 - 3077.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Pigny, R. Desailloud, C. Cortet-Rudelli, A. Duhamel, D. Deroubaix-Allard, A. Racadot, and D. Dewailly
Serum {alpha}-Inhibin Levels in Polycystic Ovary Syndrome: Relationship to the Serum Androstenedione Level
J. Clin. Endocrinol. Metab., June 1, 1997; 82(6): 1939 - 1943.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
J. E. Nestler and D. J. Jakubowicz
Decreases in Ovarian Cytochrome P450c17{alpha} Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
N. Engl. J. Med., August 29, 1996; 335(9): 617 - 623.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.